• Eosin Pharma Trenta 2% 100 g cutaneous solution
1 1

New Fadem

Eosin Pharma Trenta 2% 100 g cutaneous solution

Eosin Pharma Trenta 2% 100 g cutaneous solution

€8,84
€9,50 €8,84
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

100g

EAN

030486043

MINSAN

030486043

View full details

In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219

INDICATIONS

Local treatment for the disinfection of small wounds, abrasions, burns, insect bites, diaper rashes, bedsores and sores in general.

 

ACTIVE INGREDIENTS

EOSIN PHARMA TRENTA – 1% cutaneous solution 100 g of 1% solution contain Active ingredient: eosin 1 g. EOSIN PHARMA TRENTA 2% skin solution 100 g of 2% solution contain Active ingredient: eosin 2 g. For complete list of excipients, see par. 6.1.

 

EXCIPIENTS

2–Bromine–2–Nitropropane–1,3–Diol, imidazolidinylurea, purified water.

 

CONTRAINDICATIONS AND SIDE EFFECTS

Hypersensitivity to the active substance or to any of the excipients.

 

DOSAGE

Apply a few drops 1 – 2 times a day, using clean gauze or pour directly onto the area to be treated; cover if necessary with an appropriate dry sterile bandage.

 

CONSERVATION

Store in a tightly closed container, protected from light.

 

WARNINGS

Avoid application near the eyes. Eosin cutaneous solution colors the skin red; the spots disappear in about three days. Important information about some excipients: None in particular

 

INTERACTIONS

There are no known interactions with other drugs.

 

SIDE EFFECTS

Below are the side effects of eosin, organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. Immune system disorders – Hypersensitivity reactions Skin and subcutaneous tissue disorders – Contact dermatitis

 

OVERDOSE

No toxic phenomena due to overdose are known.

 

PREGNANCY AND BREASTFEEDING

Since systemic absorption is negligible, no negative effects are foreseeable for the fetus during pregnancy and for the child during breastfeeding.

 

EFFECTS ON DRIVING ABILITY

Eosin does not alter the ability to drive or use machines.

OUR PRODUCTS FOR THIS SEASON

1 10
View all
1 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.